Increased apolipoprotein E and decreased TNF‐α in the cerebrospinal fluid of nondemented APOE‐ε4 carriers
Open Access
- 19 May 2020
- journal article
- research article
- Published by Wiley in Neuropsychopharmacology Reports
- Vol. 40 (2), 201-205
- https://doi.org/10.1002/npr2.12110
Abstract
Aim The ε4 allele of apolipoprotein E gene (APOE) is a well‐known risk factor of late‐onset Alzheimer's disease. However, little is known why this variant confers a risk for Alzheimer's disease. The aim of this study was to examine the influence of the APOE genotype on cerebrospinal fluid (CSF) protein levels. Methods The present study performed a secondary analysis on our previously generated database to compare the CSF levels of 1128 proteins between APOE‐ε4 carriers (28 subjects) and noncarriers (104 subjects). All subjects were physically healthy Japanese individuals without dementia. Results CSF levels of apoE2, apoE3, and apoE4 were significantly higher (all nominal P < 10 × 10−5, false discovery rate < 0.001) and those of tumor necrosis factor‐α (TNF‐α) were significantly lower (nominal P = 1.39 × 10−6, false discovery rate < 0.001) in APOE‐ε4 carriers than in noncarriers. No significant correlation was observed between the CSF levels of TNF‐α and any of the apoE proteins. Conclusions Our findings indicate the possible roles of apoE and TNF‐α in the pathogenesis of APOE‐ε4‐associated Alzheimer's disease.Keywords
Funding Information
- Japan Agency for Medical Research and Development (17ak0101044h0402)
This publication has 20 references indexed in Scilit:
- Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorderScientific Reports, 2015
- Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controlsActa Neuropathologica, 2014
- Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorderJournal of Psychiatric Research, 2013
- Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's diseaseHuman Molecular Genetics, 2012
- Advances in human proteomics at high scale with the SOMAscan proteomics platformNew Biotechnology, 2012
- The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesteraseNeurobiology of Aging, 2011
- Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseNature Reviews Neurology, 2010
- Intrathecal inflammation precedes development of Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Apolipoprotein E suppresses glial cell secretion of TNFαJournal of Neuroimmunology, 1997
- Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's diseaseHuman Genetics, 1995